Metabolomic response of chlamydomonas reinhardtii to the s inhibition of target of rapamycin (tor) by rapamycin

Do Yup Lee, Oliver Fiehn

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Rapamycin, known as an inhibitor of Target of Rapamycin (TOR), is an immunosuppressant drug used to prevent rejection in organ transplantation. Despite the close association of the TOR signaling cascade with various scopes of metabolism, it has not yet been thoroughly investigated at the metabolome level. In our current study, we applied mass spectrometric analysis for profiling primary metabolism in order to capture the responsive dynamics of the Chlamydomonas metabolome to the inhibition of TOR by rapamycin. Accordingly, we identified the impact of the rapamycin treatment at the level of metabolomic phenotypes that were clearly distinguished by multivariate statistical analysis. Pathway analysis pinpointed that inactivation of the TCA cycle was accompanied by the inhibition of cellular growth. Relative to the constant suppression of the TCA cycle, most amino acids were significantly increased in a time-dependent manner by longer exposure to rapamycin treatment, after an initial down-regulation at the early stage of exposure. Finally, we explored the isolation of the responsive metabolic factors into the rapamycin treatment and the culture duration, respectively.

Original languageEnglish (US)
Pages (from-to)923-931
Number of pages9
JournalJournal of Microbiology and Biotechnology
Volume23
Issue number7
DOIs
StatePublished - 2013

Fingerprint

Chlamydomonas reinhardtii
Metabolomics
Sirolimus
Metabolome
Chlamydomonas
Organ Transplantation
Immunosuppressive Agents
Down-Regulation
Multivariate Analysis
Phenotype
Amino Acids

Keywords

  • Chlamydomonas reinhardtii
  • Mass spectrometry
  • Metabolomics
  • Target of rapamycin

ASJC Scopus subject areas

  • Biotechnology
  • Applied Microbiology and Biotechnology

Cite this

Metabolomic response of chlamydomonas reinhardtii to the s inhibition of target of rapamycin (tor) by rapamycin. / Lee, Do Yup; Fiehn, Oliver.

In: Journal of Microbiology and Biotechnology, Vol. 23, No. 7, 2013, p. 923-931.

Research output: Contribution to journalArticle

@article{1d0a30977792486886a55c48e82354e0,
title = "Metabolomic response of chlamydomonas reinhardtii to the s inhibition of target of rapamycin (tor) by rapamycin",
abstract = "Rapamycin, known as an inhibitor of Target of Rapamycin (TOR), is an immunosuppressant drug used to prevent rejection in organ transplantation. Despite the close association of the TOR signaling cascade with various scopes of metabolism, it has not yet been thoroughly investigated at the metabolome level. In our current study, we applied mass spectrometric analysis for profiling primary metabolism in order to capture the responsive dynamics of the Chlamydomonas metabolome to the inhibition of TOR by rapamycin. Accordingly, we identified the impact of the rapamycin treatment at the level of metabolomic phenotypes that were clearly distinguished by multivariate statistical analysis. Pathway analysis pinpointed that inactivation of the TCA cycle was accompanied by the inhibition of cellular growth. Relative to the constant suppression of the TCA cycle, most amino acids were significantly increased in a time-dependent manner by longer exposure to rapamycin treatment, after an initial down-regulation at the early stage of exposure. Finally, we explored the isolation of the responsive metabolic factors into the rapamycin treatment and the culture duration, respectively.",
keywords = "Chlamydomonas reinhardtii, Mass spectrometry, Metabolomics, Target of rapamycin",
author = "Lee, {Do Yup} and Oliver Fiehn",
year = "2013",
doi = "/10.4014/jmb.1304.04057",
language = "English (US)",
volume = "23",
pages = "923--931",
journal = "Journal of Microbiology and Biotechnology",
issn = "1017-7825",
publisher = "Korean Society for Microbiolog and Biotechnology",
number = "7",

}

TY - JOUR

T1 - Metabolomic response of chlamydomonas reinhardtii to the s inhibition of target of rapamycin (tor) by rapamycin

AU - Lee, Do Yup

AU - Fiehn, Oliver

PY - 2013

Y1 - 2013

N2 - Rapamycin, known as an inhibitor of Target of Rapamycin (TOR), is an immunosuppressant drug used to prevent rejection in organ transplantation. Despite the close association of the TOR signaling cascade with various scopes of metabolism, it has not yet been thoroughly investigated at the metabolome level. In our current study, we applied mass spectrometric analysis for profiling primary metabolism in order to capture the responsive dynamics of the Chlamydomonas metabolome to the inhibition of TOR by rapamycin. Accordingly, we identified the impact of the rapamycin treatment at the level of metabolomic phenotypes that were clearly distinguished by multivariate statistical analysis. Pathway analysis pinpointed that inactivation of the TCA cycle was accompanied by the inhibition of cellular growth. Relative to the constant suppression of the TCA cycle, most amino acids were significantly increased in a time-dependent manner by longer exposure to rapamycin treatment, after an initial down-regulation at the early stage of exposure. Finally, we explored the isolation of the responsive metabolic factors into the rapamycin treatment and the culture duration, respectively.

AB - Rapamycin, known as an inhibitor of Target of Rapamycin (TOR), is an immunosuppressant drug used to prevent rejection in organ transplantation. Despite the close association of the TOR signaling cascade with various scopes of metabolism, it has not yet been thoroughly investigated at the metabolome level. In our current study, we applied mass spectrometric analysis for profiling primary metabolism in order to capture the responsive dynamics of the Chlamydomonas metabolome to the inhibition of TOR by rapamycin. Accordingly, we identified the impact of the rapamycin treatment at the level of metabolomic phenotypes that were clearly distinguished by multivariate statistical analysis. Pathway analysis pinpointed that inactivation of the TCA cycle was accompanied by the inhibition of cellular growth. Relative to the constant suppression of the TCA cycle, most amino acids were significantly increased in a time-dependent manner by longer exposure to rapamycin treatment, after an initial down-regulation at the early stage of exposure. Finally, we explored the isolation of the responsive metabolic factors into the rapamycin treatment and the culture duration, respectively.

KW - Chlamydomonas reinhardtii

KW - Mass spectrometry

KW - Metabolomics

KW - Target of rapamycin

UR - http://www.scopus.com/inward/record.url?scp=84880677727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880677727&partnerID=8YFLogxK

U2 - /10.4014/jmb.1304.04057

DO - /10.4014/jmb.1304.04057

M3 - Article

C2 - 23727803

AN - SCOPUS:84880677727

VL - 23

SP - 923

EP - 931

JO - Journal of Microbiology and Biotechnology

JF - Journal of Microbiology and Biotechnology

SN - 1017-7825

IS - 7

ER -